You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 26, 2024

Rising Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for RISING, and what generic and branded alternatives to RISING drugs are available?

RISING has two hundred and seventy-one approved drugs.

There are three tentative approvals on RISING drugs.

Summary for Rising

US Patents:	0
Tradenames:	218
Ingredients:	214
NDAs:	271

Drugs and US Patents for Rising

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rising	ROPIVACAINE HYDROCHLORIDE	ropivacaine hydrochloride	SOLUTION;INJECTION	090318-004	Sep 23, 2014		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Rising	NORTRIPTYLINE HYDROCHLORIDE	nortriptyline hydrochloride	CAPSULE;ORAL	074234-003	Jul 26, 1993		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Rising	OLMESARTAN MEDOXOMIL	olmesartan medoxomil	TABLET;ORAL	078276-002	Oct 26, 2016		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Rising	ONDANSETRON HYDROCHLORIDE	ondansetron hydrochloride	TABLET;ORAL	076930-004	Jun 25, 2007		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Rising	NIFEDIPINE	nifedipine	TABLET, EXTENDED RELEASE;ORAL	201071-002	Dec 3, 2010		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Rising	SULFISOXAZOLE	sulfisoxazole	TABLET;ORAL	085628-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Rising	LORAZEPAM	lorazepam	INJECTABLE;INJECTION	200217-001	Apr 4, 2017		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Rising

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Rising	SULFAMYLON	mafenide acetate	CREAM;TOPICAL	016763-001	Approved Prior to Jan 1, 1982	3,497,599	⤷ Sign Up
Rising	SUFENTA PRESERVATIVE FREE	sufentanil citrate	INJECTABLE;INJECTION	019050-001	May 4, 1984	3,998,834	⤷ Sign Up
Rising	ALFENTA	alfentanil hydrochloride	INJECTABLE;INJECTION	019353-001	Dec 29, 1986	4,167,574	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.